|
[1]SPALDING AC, JEE KW, VINEBERG K, et al.Potential for doseescalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and g EUD-based cost functions[J].Med Phys, 2007, 34 (2) :521-529.
|
|
[2]MOERTEL CG, FRYTAK S, HAHN RG, et al.Therapy of locally unresectable pancreatic carcinoma:a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000rads+5-fluorouracil) , and high dose radiation+5-fluorouracil:The Gastrointestinal Tumor Study Group[J].Cancer, 1981, 48 (8) :1705-1710.
|
|
[3]CHAUFFERT B, MORNEX F, BONNETAIN F, et al.Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer.Definitive results of the 2000-01 FFCD/SFRO study[J].Ann Oncol, 2008, 19 (9) :1592-1599.
|
|
[4]LOEHRER PJ SR, FENG Y, CARDENES H, et al.Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer:an Eastern Cooperative Oncology Group trial[J].J Clin Oncol, 2011, 29 (31) :4105-4112.
|
|
[5]HAMMEL P, HUGUET F, VAN LJ-LEA.Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib:final results of the international phase III LAP 07 study[J].J Clin Oncol, 2013, 31 (Suppl) :LBA4003.
|
|
[6]SMEENK HG, van EIJCK CH, HOP WC, et al.Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation:long-term results of EORTC trial 40891[J].Ann Surg, 2007, 246 (5) :734-740.
|
|
[7]NEOPTOLEMOS JP, STOCKEN DD, FRIESS H, et al.A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer[J].N Engl J Med, 2004, 350 (12) :1200-1210.
|
|
[8]Mc DADE TP, HILL JS, SIMONS JP, et al.A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma[J].Cancer, 2010, 116 (13) :3257-3266.
|
|
[9]STOCKEN DD, BUCHLER MW, DERVENIS C, et al.Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer[J].Br J Cancer, 2005, 92 (8) :1372-1381.
|
|
[10]BRESLIN TM, HESS KR, HARBISON DB, et al.Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas:treatment variables and survival duration[J].Ann Surg Oncol, 2001, 8 (2) :123-132.
|
|
[11]VARADHACHARY GR, WOLFF RA, CRANE CH, et al.Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head[J].J Clin Oncol, 2008, 26 (21) :3487-3495.
|
|
[12]LAURENCE JM, TRAN PD, MORARJI K, et al.A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer[J].J Gastrointest Surg, 2011, 15 (11) :2059-2069.
|
|
[13]WANG J, XIA TY, WANG YJ, et al.Long-term results of gamma ray-based stereotactic body radiotherapy in treatment of medically unfit or inoperable non-metastatic pancreatic adenocarcinoma[J].Int J Radiat Oncol Biol Phys, 2012, 84 (Suppl) :s815-s816.
|
|
[14]CHANG DS, LI P, WANG YJ, et al.Clinical outcomes of whole body gamma knife therapy for local pancreatic carcinoma[J].Chin J Radiat Oncol, 2009, 18 (6) :470-473. (in Chinese) 常冬姝, 李平, 王颖杰, 等.全身γ刀治疗局限期胰腺癌临床结果分析[J].中华放射肿瘤学杂志, 2009, 18 (6) :470-473.
|
|
[15]LI G, YU YY, HAN C, et al.Efficacy analysis of three-dimensional conformal radiotherapy with increasing dose in late course in pancreatic cancer pantients[J].J Chin Med Univ, 2012, 41 (12) :1134-1143. (in Chinese) 李光, 于洋洋, 韩冲, 等.81例胰腺癌后程加量三维适形放疗的疗效分析[J].中国医科大学学报, 2012, 41 (12) :1134-1143.
|
|
[16]NAKAMURA A, SHIBUYA K, MATSUO Y, et al.Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy[J].Int J Radiat Oncol Biol Phys, 2012, 84 (2) :369-375.
|
|
[17]YOVINO S, POPPE M, JABBOUR S, et al.Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers[J].Int J Radiat Oncol Biol Phys, 2011, 79 (1) :158-162.
|
|
[18]CHANG DT, SCHELLENBERG D, SHEN J, et al.Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas[J].Cancer, 2009, 115 (3) :665-672.
|
|
[19]XIA TY, CHANG DS, WANG YJ, et al.Dose escalation to target volumes of helical tomotherapy for pancreatic cancer in the phase I-II clinical trial[J].Int J Radiat Oncol Biol Phys, 2013, 87 (Suppl) :s303.
|
DownLoad: